Cover Image
市場調查報告書

心臟心律調節器的全球市場:醫療設備的開發平台評估

Cardiac Pacemakers - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 363397
出版日期 內容資訊 英文 135 Pages
訂單完成後即時交付
價格
Back to Top
心臟心律調節器的全球市場:醫療設備的開發平台評估 Cardiac Pacemakers - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年09月08日 內容資訊: 英文 135 Pages
簡介

本報告提供全球心臟心律調節器的市場上之主要開發中產品及其臨床實驗的進展調查,再彙整產品功能·特性比較分析 (臨床實驗的各進展階段) ,以及主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 心臟心律調節器概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:推算各認證時期
  • 開發中產品:現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 心臟心律調節器的企業:各臨床實驗階段的開發中產品
  • 心臟心律調節器:各臨床實驗階段的開發中產品

第5章 心臟心律調節器市場:企業·產品概要

  • Boston Scientific Corporation
    • 開發中產品及進行中的臨床實驗概要
  • Boston TransTec, LLC
  • Duke University
  • EBR Systems, Inc.
  • Hadasit Medical Research Services & Development Ltd
  • InnerPulse, Inc.
  • Kenergy Inc.
  • Krisara Engineering, LLC
  • LivaNova PLC
  • Mathematical Bio-Solutions Inc.
  • Mayo Clinic US
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NDSU Research Foundation
  • NuVascular Technologies Inc
  • Perpetuum Ltd.
  • St. Jude Medical, Inc.
  • University of Bern
  • University of California, Los Angeles
  • University of Michigan

第6章 心臟心律調節器市場:目前的趨勢 (全63件)

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0442EPD

GlobalData's Medical Devices sector report, "Cardiac Pacemakers - Medical Devices Pipeline Assessment, 2017" provides an overview of Cardiac Pacemakers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Pacemakers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Pacemakers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Pacemakers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Pacemakers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 7

2 Introduction 8

  • 2.1 Cardiac Pacemakers Overview 8

3 Products under Development 9

  • 3.1 Cardiac Pacemakers - Pipeline Products by Stage of Development 9
  • 3.2 Cardiac Pacemakers - Pipeline Products by Segment 10
  • 3.3 Cardiac Pacemakers - Pipeline Products by Territory 11
  • 3.4 Cardiac Pacemakers - Pipeline Products by Regulatory Path 12
  • 3.5 Cardiac Pacemakers - Pipeline Products by Estimated Approval Date 13
  • 3.6 Cardiac Pacemakers - Ongoing Clinical Trials 14

4 Cardiac Pacemakers - Pipeline Products under Development by Companies 15

  • 4.1 Cardiac Pacemakers Companies - Pipeline Products by Stage of Development 15
  • 4.2 Cardiac Pacemakers - Pipeline Products by Stage of Development 17

5 Cardiac Pacemakers Companies and Product Overview 18

  • 5.1 BackBeat Medical, Inc. Company Overview 18
    • 5.1.1 BackBeat Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.2 Ben-Gurion University of the Negev Company Overview 21
    • 5.2.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.3 Boston Scientific Corp Company Overview 22
    • 5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.4 Boston TransTec LLC Company Overview 24
    • 5.4.1 Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.5 Columbia University Company Overview 25
    • 5.5.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.6 Duke University Company Overview 26
    • 5.6.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.7 EBR Systems Inc Company Overview 27
    • 5.7.1 EBR Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.8 Hadasit Medical Research Services and Development Ltd Company Overview 32
    • 5.8.1 Hadasit Medical Research Services and Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.9 InnerPulse, Inc. Company Overview 33
    • 5.9.1 InnerPulse, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.10 Kenergy Inc. Company Overview 34
    • 5.10.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.11 Krisara Engineering, LLC Company Overview 35
    • 5.11.1 Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.12 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 36
    • 5.12.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.13 LivaNova PLC Company Overview 37
    • 5.13.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.14 Mathematical Bio-Solutions Inc. Company Overview 44
    • 5.14.1 Mathematical Bio-Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.15 Mayo Clinic US Company Overview 45
    • 5.15.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.16 Medtronic plc Company Overview 46
    • 5.16.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.17 MicroPort Scientific Corp Company Overview 50
    • 5.17.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.18 NDSU Research Foundation Company Overview 52
    • 5.18.1 NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.19 NuVascular Technologies Inc Company Overview 53
    • 5.19.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.20 Osypka Medical GmbH Company Overview 54
    • 5.20.1 Osypka Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.21 Perpetuum Ltd. Company Overview 55
    • 5.21.1 Perpetuum Ltd. Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.22 Rice University Company Overview 56
    • 5.22.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.23 St. Jude Medical LLC Company Overview 57
    • 5.23.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.24 U.S. Stem Cell Inc Company Overview 60
    • 5.24.1 U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.25 University of Bern Company Overview 61
    • 5.25.1 University of Bern Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.26 University of California Los Angeles Company Overview 62
    • 5.26.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.27 University of Michigan Company Overview 63
    • 5.27.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 63

6 Cardiac Pacemakers - Recent Developments 64

  • 6.1 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 64
  • 6.2 Aug 17, 2017: First Leadless Pacemaker has been inserted at Peninsula Private Hospital 66
  • 6.3 Aug 17, 2017: First Leadless Pacemaker has been inserted at Peninsula Private Hospital 66
  • 6.4 Aug 09, 2017: LivaNova Reports Second Quarter 2017 Results 67
  • 6.5 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 68
  • 6.6 Jul 27, 2017: Integer Holdings Reports Second Quarter 2017 Results 70
  • 6.7 Jul 17, 2017: Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer 71
  • 6.8 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 71
  • 6.9 Jun 20, 2017: EBR Systems Awarded Favorite Innovation for WiSE CRT at 2017 EHRA Europace Cardiostim Congress 73
  • 6.10 Jun 19, 2017: Europace-Cardiostim 2017: Challenges and New Opportunities in Heart Failure Management 74
  • 6.11 Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel 75
  • 6.12 Jun 05, 2017: Rice University: Texas team debuts battery-less pacemaker 75
  • 6.13 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 76
  • 6.14 May 18, 2017: World's smallest, leadless pacemaker yields positive results in Emory-led study 79
  • 6.15 May 16, 2017: LivaNova Announces Thad Huston as Chief Financial Officer 80
  • 6.16 May 11, 2017: New Medtronic Study Reinforces Safety and Performance of the World's Smallest Pacemaker in a Real-World Patient Population 80
  • 6.17 May 10, 2017: Battery-free implantable medical device draws energy directly from human body 82
  • 6.18 May 08, 2017: Integer Holdings Reports First Quarter 2017 Results 83
  • 6.19 May 03, 2017: LivaNova Reports First Quarter 2017 Results 84
  • 6.20 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 85
  • 6.21 Mar 31, 2017: LivaNova Announces Chief Financial Officer Resignation 86
  • 6.22 Mar 31, 2017: LivaNova Reiterates Full-Year 2017 Guidance 87
  • 6.23 Mar 27, 2017: Integer Announces Leadership Change 87
  • 6.24 Mar 20, 2017: BIOTRONIK Launches its Smallest and Lightest MR-Conditional Pacemakers and a New Range of Quadripolar CRT-Ps with MRI AutoDetect 88
  • 6.25 Mar 16, 2017: Nynex Therapeutics Launched to Target Oncogenic Proteins in the Treatment of Cancer 88
  • 6.26 Mar 10, 2017: Medtronic Announces Medicare Reimbursement for the First and Only Leadless Pacemaker Available for Use in the U.S. 89
  • 6.27 Mar 01, 2017: LivaNova Reports Fourth Quarter and Full-Year 2016 Results 90
  • 6.28 Feb 27, 2017: Gary Haire to Join Integer as Executive Vice President and Chief Financial Officer 93
  • 6.29 Feb 27, 2017: Integer Holdings Reports Results for Fourth Quarter and Full Year 2016 94
  • 6.30 Feb 23, 2017: LivaNova Announces Its Intent to Delist from London Stock Exchange 96
  • 6.31 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 97
  • 6.32 Feb 20, 2017: World's Smallest Pacemaker Available to Wake Forest Baptist Patients 99
  • 6.33 Feb 17, 2017: Medtronic Announces Japanese Regulatory Approval For Micra Transcatheter Pacing System 100
  • 6.34 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 101
  • 6.35 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 102
  • 6.36 Feb 01, 2017: Abbott Announces U.S. Approval for its Assurity MRI Pacemaker, the World's Smallest, Longest-Lasting Wireless MRI-Compatible Pacemaker 103
  • 6.37 Jan 26, 2017: Medtronic Announces Medicare Coverage Decision for the First and Only Leadless Pacemaker Available for Use in the U.S. 104
  • 6.38 Nov 29, 2016: Clinical Data for BackBeat Medical's Programmable Hypertension Control Therapy to Be Presented at ICI Meeting 2016 105
  • 6.39 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 106
  • 6.40 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 108
  • 6.41 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 109
  • 6.42 Nov 02, 2016: LivaNova Announces CEO Transition: Damien McDonald to Succeed Andre-Michel Ballester 110
  • 6.43 Nov 02, 2016: LivaNova Reports Third Quarter 2016 Results 110
  • 6.44 Oct 31, 2016: BackBeat Medical Clinical Data Presented at TCT 2016 Show Continued Reduction in Blood Pressure Over One Year with Cardiac Pacing-Based Hypertension Treatment 112
  • 6.45 Oct 26, 2016: Clinical Data for BackBeat Medical's Programmable Hypertension Control Therapy to Be Presented at TCT 2016 112
  • 6.46 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 113
  • 6.47 Oct 26, 2016: Nihon Kohden Announces Consolidation and Relocation of Offices 114
  • 6.48 Oct 22, 2016: World's Smallest Pacemaker Licenced for Canadian Patients 115
  • 6.49 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 116
  • 6.50 Oct 13, 2016: Medtronic Cardiac Devices Gain FDA Approval to Enable Patient Access to the Most Advanced Diagnostic Imaging 118
  • 6.51 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 119
  • 6.52 Sep 29, 2016: BIOTRONIK Begins Manufacturing High-Tech Products in Singapore 119
  • 6.53 Sep 29, 2016: LivaNova Announces Half-Year Financial Report 120
  • 6.54 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 128
  • 6.55 Sep 13, 2016: EBR Systems Receives FDA Approval to Begin U.S. Pivotal Study of Wireless Cardiac Pacing System for Heart Failure 129

7 Appendix 132

  • 7.1 Methodology 132
  • 7.2 About GlobalData 135
  • 7.3 Contact Us 135
  • 7.4 Disclaimer 135

List of Tables

1.1 List of Tables

  • Table 1: Cardiac Pacemakers - Pipeline Products by Stage of Development 9
  • Table 2: Cardiac Pacemakers - Pipeline Products by Segment 10
  • Table 3: Cardiac Pacemakers - Pipeline Products by Territory 11
  • Table 4: Cardiac Pacemakers - Pipeline Products by Regulatory Path 12
  • Table 5: Cardiac Pacemakers - Pipeline Products by Estimated Approval Date 13
  • Table 6: Cardiac Pacemakers - Ongoing Clinical Trials 14
  • Table 7: Cardiac Pacemakers Companies - Pipeline Products by Stage of Development 15
  • Table 8: Cardiac Pacemakers - Pipeline Products by Stage of Development 17
  • Table 9: BackBeat Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 10: Moderato - Product Status 18
  • Table 11: Moderato - Product Description 18
  • Table 12: BackBeat Medical, Inc. - Ongoing Clinical Trials Overview 19
  • Table 13: Moderato - Clinical Evaluation of Safety and Effectiveness of the BackBeat Medical Moderato System in Patients with Hypertension - A Double-Blind Randomized Trial - PV Loops Sub Study 20
  • Table 14: Moderato - Clinical Evaluation of Safety and Effectiveness of the BackBeat Medical Moderato System in Patients with Hypertension: A Double-blind Randomized Trial 20
  • Table 15: Moderato - Clinical Evaluation of Safety and Performance of the BackBeat Moderato System 20
  • Table 16: Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 17: Heart Pacing System - Product Status 21
  • Table 18: Heart Pacing System - Product Description 21
  • Table 19: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 20: EMPOWER Modular Pacing System - Product Status 22
  • Table 21: EMPOWER Modular Pacing System - Product Description 22
  • Table 22: INGENIO 2 PG - MICS - Product Status 23
  • Table 23: INGENIO 2 PG - MICS - Product Description 23
  • Table 24: Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 25: Raul Pacemaker - Product Status 24
  • Table 26: Raul Pacemaker - Product Description 24
  • Table 27: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 28: Biological Pacemaker - Product Status 25
  • Table 29: Biological Pacemaker - Product Description 25
  • Table 30: Duke University Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 31: Tissue-Engineered Autonomous Pacemaker - Product Status 26
  • Table 32: Tissue-Engineered Autonomous Pacemaker - Product Description 26
  • Table 33: EBR Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 34: Second Generation WiSE CRT System - Product Status 27
  • Table 35: Second Generation WiSE CRT System - Product Description 27
  • Table 36: WiSE CRT System - Product Status 28
  • Table 37: WiSE CRT System - Product Description 28
  • Table 38: EBR Systems Inc - Ongoing Clinical Trials Overview 29
  • Table 39: WiSE CRT System - Multicenter, Prospective Evaluation of Safety and Performance of the WiCS-LV System in Patients Indicated for Cardiac Resynchronization Therapy 30
  • Table 40: WiSE CRT System - WiCS-LV Post Market Surveillance Registry 30
  • Table 41: Second Generation WiSE CRT System - Stimulation of the Left Ventricle Endocardially-CRT study (SOLVE-CRT) 31
  • Table 42: Hadasit Medical Research Services and Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 43: Aortic Pacemaker - Product Status 32
  • Table 44: Aortic Pacemaker - Product Description 32
  • Table 45: InnerPulse, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 46: InnerPulse Pacemaker - Product Status 33
  • Table 47: InnerPulse Pacemaker - Product Description 33
  • Table 48: Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 49: Unconditional MRI Compatible Implantable Pacemaker - Product Status 34
  • Table 50: Unconditional MRI Compatible Implantable Pacemaker - Product Description 34
  • Table 51: Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 52: Wireless Pacemaker - Product Status 35
  • Table 53: Wireless Pacemaker - Product Description 35
  • Table 54: Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 55: HeartTone - Product Status 36
  • Table 56: HeartTone - Product Description 36
  • Table 57: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 58: KORA 100 Pacing System - Product Status 37
  • Table 59: KORA 100 Pacing System - Product Description 38
  • Table 60: REPLY 200 DR - Product Status 38
  • Table 61: REPLY 200 DR - Product Description 38
  • Table 62: REPLY 200 SR - Product Status 39
  • Table 63: REPLY 200 SR - Product Description 39
  • Table 64: Reply MRI Pacemaker - Product Status 39
  • Table 65: Reply MRI Pacemaker - Product Description 40
  • Table 66: LivaNova PLC - Ongoing Clinical Trials Overview 41
  • Table 67: REPLY 200 SR - Sustainability of Cardiology Services: Economic Evaluation and Communication in Remote Monitoring of People with Pacemakers 42
  • Table 68: REPLY 200 DR - Sustainability of Cardiology Services: Economic Evaluation and Communication in Remote Monitoring of People with Pacemakers 43
  • Table 69: Mathematical Bio-Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 70: ECN Pacemaker - Product Status 44
  • Table 71: ECN Pacemaker - Product Description 44
  • Table 72: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 73: Temporary Epicardial Pacemaker - Product Status 45
  • Table 74: Temporary Epicardial Pacemaker - Product Description 45
  • Table 75: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 76: Azure Pacemaker - Product Status 46
  • Table 77: Azure Pacemaker - Product Description 46
  • Table 78: Brady Wireless - Product Status 47
  • Table 79: Brady Wireless - Product Description 47
  • Table 80: Heart Pacemaker - Product Status 47
  • Table 81: Heart Pacemaker - Product Description 47
  • Table 82: Micra AAIR Pacemaker - Product Status 48
  • Table 83: Micra AAIR Pacemaker - Product Description 48
  • Table 84: Micra DDDR Pacemaker - Product Status 48
  • Table 85: Micra DDDR Pacemaker - Product Description 49
  • Table 86: Micra VDDR Pacemaker - Product Status 49
  • Table 87: Micra VDDR Pacemaker - Product Description 49
  • Table 88: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 89: Implantable Pulse Generator - Product Status 50
  • Table 90: Implantable Pulse Generator - Product Description 50
  • Table 91: MicroPort Pacemaker - Product Status 51
  • Table 92: MicroPort Pacemaker - Product Description 51
  • Table 93: NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 94: Multi-Electrode Cardiac Pacing System - Product Status 52
  • Table 95: Multi-Electrode Cardiac Pacing System - Product Description 52
  • Table 96: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 97: Biological Pacemaker - Product Status 53
  • Table 98: Biological Pacemaker - Product Description 53
  • Table 99: Osypka Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 100: PACE 300 - Product Status 54
  • Table 101: PACE 300 - Product Description 54
  • Table 102: Perpetuum Ltd. Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 103: Implantable Self-Energising Pacemaker - Product Status 55
  • Table 104: Implantable Self-Energising Pacemaker - Product Description 55
  • Table 105: Rice University Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 106: Battery-Less Pacemaker - Product Status 56
  • Table 107: Battery-Less Pacemaker - Product Description 56
  • Table 108: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 109: Nanostim Leadless Pacemaker - Product Status 57
  • Table 110: Nanostim Leadless Pacemaker - Product Description 57
  • Table 111: St. Jude Medical LLC - Ongoing Clinical Trials Overview 58
  • Table 112: Nanostim Leadless Pacemaker - Nanostim Study for a Leadless Cardiac Pacemaker System 59
  • Table 113: U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 114: BioPace - Product Status 60
  • Table 115: BioPace - Product Description 60
  • Table 116: University of Bern Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 117: Batteryless Cardiac Pacemaker - Product Status 61
  • Table 118: Batteryless Cardiac Pacemaker - Product Description 61
  • Table 119: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 120: MR3 Next-Generation Pacemaker - Product Status 62
  • Table 121: MR3 Next-Generation Pacemaker - Product Description 62
  • Table 122: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 123: Cardiac Energy Harvesting Pacemaker - Product Status 63
  • Table 124: Cardiac Energy Harvesting Pacemaker - Product Description 63
  • Table 125: Glossary 134

List of Figures

1.2 List of Figures

  • Figure 1: Cardiac Pacemakers - Pipeline Products by Stage of Development 9
  • Figure 2: Cardiac Pacemakers - Pipeline Products by Segment 10
  • Figure 3: Cardiac Pacemakers - Pipeline Products by Territory 11
  • Figure 4: Cardiac Pacemakers - Pipeline Products by Regulatory Path 12
  • Figure 5: Cardiac Pacemakers - Pipeline Products by Estimated Approval Date 13
  • Figure 6: Cardiac Pacemakers - Ongoing Clinical Trials 14
Back to Top